The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 7.34%% during the fourth quarter of 2024. Read more here.
PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback